We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
-0.46%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$965M
AUM Growth
-$32.4M
Cap. Flow
-$6.96M
Cap. Flow %
-0.72%
Top 10 Hldgs %
14.62%
Holding
124
New
8
Increased
41
Reduced
62
Closed
5

Top Buys

Rank Stock Value
1
SWIM icon
Latham Group
SWIM
+$11.3M
2
APLS
Apellis Pharmaceuticals
APLS
+$8.77M
3
POSH
Poshmark, Inc. Class A Common Stock
POSH
+$8.26M
4
BLND icon
Blend Labs
BLND
+$7.42M
5
MXCT icon
MaxCyte
MXCT
+$7.37M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$10.9M
2
RAVN
Raven Industries Inc
RAVN
+$10.6M
3
FIVN icon
FIVE9
FIVN
+$9.79M
4
SPT icon
Sprout Social
SPT
+$7.13M
5
PZZA icon
Papa John's
PZZA
+$6.98M

Sector Composition

Rank Sector Weight
1 Technology 28.88%
2 Healthcare 23.27%
3 Industrials 16.26%
4 Consumer Discretionary 12.5%
5 Financials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HQY icon
76
HealthEquity
HQY
$8.83B
$7.21M 0.75%
111,281
-12,473
-10% -$866K
TTGT icon
77
TechTarget
TTGT
$265M
$7.09M 0.74%
86,087
-39,672
-32% -$3.15M
ALEC icon
78
Alector
ALEC
$228M
$7M 0.72%
306,536
-30,378
-9% -$851K
PGNY icon
79
Progyny
PGNY
$1.99B
$6.93M 0.72%
123,769
-17,999
-13% -$994K
ADPT icon
80
Adaptive Biotechnologies
ADPT
$3.89B
$6.71M 0.7%
197,492
-2,205
-1% -$79.7K
MYOV
81
DELISTED
Myovant Sciences Ltd.
MYOV
$6.57M 0.68%
292,976
-7,640
-3% -$168K
LASR icon
82
nLIGHT
LASR
$3.06B
$6.37M 0.66%
225,958
-117,571
-34% -$3.5M
SDGR icon
83
Schrodinger
SDGR
$1.38B
$6.26M 0.65%
114,489
+28,317
+33% +$1.81M
DV icon
84
DoubleVerify
DV
$2.04B
$6.23M 0.65%
182,292
+40,518
+29% +$1.43M
BLFS icon
85
BioLife Solutions
BLFS
$1.72B
$6.05M 0.63%
142,876
-2,269
-2% -$109K
MXCT icon
86
MaxCyte
MXCT
$149M
$5.97M 0.62%
+488,673
New +$7.37M
BLND icon
87
Blend Labs
BLND
$331M
$5.89M 0.61%
+436,789
New +$7.42M
PSNL icon
88
Personalis
PSNL
$1.54B
$5.83M 0.6%
302,786
-7,830
-3% -$164K
CYRX icon
89
CryoPort
CYRX
$766M
$5.81M 0.6%
87,404
-102,942
-54% -$6.35M
ALXO icon
90
ALX Oncology
ALXO
$278M
$5.57M 0.58%
+75,362
New +$5.02M
APLS
91
DELISTED
Apellis Pharmaceuticals
APLS
$5.14M 0.53%
+156,031
New +$8.77M
LGIH icon
92
LGI Homes
LGIH
$1.32B
$5.09M 0.53%
35,878
+5,466
+18% +$863K
AVXL icon
93
Anavex Life Sciences
AVXL
$316M
$4.96M 0.51%
+276,183
New +$5.5M
ATEC icon
94
Alphatec Holdings
ATEC
$1.49B
$4.87M 0.5%
399,625
-273,151
-41% -$3.81M
IBP icon
95
Installed Building Products
IBP
$6.46B
$4.82M 0.5%
45,004
-45,860
-50% -$5.47M
RVNC
96
DELISTED
Revance Therapeutics, Inc.
RVNC
$4.62M 0.48%
165,913
-4,403
-3% -$126K
VAPO
97
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$4.13M 0.43%
+23,163
New +$4.71M
IMCR icon
98
Immunocore
IMCR
$1.77B
$2.91M 0.3%
+78,514
New +$2.65M
PODD icon
99
Insulet
PODD
$10.1B
$1.04M 0.11%
3,674
-1,452
-28% -$414K
MSCI icon
100
MSCI
MSCI
$40.9B
$989K 0.1%
1,625
+776
+91% +$474K
1 2 3
4
5

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MGM
Manchester Global Management London, United Kingdom $749M AUM 37.16% 1-Year Est. Return

Pier Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Pier Capital held 124 positions worth $965M, down 3.2% from $997M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Pier Capital's Q3 2021 filing shows 8 new, 41 increased, 62 reduced and 5 closed positions. Its largest new stake was Latham Group: 485,886 shares worth $7.97M. The largest sale was TG Therapeutics, an estimated $10.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Pier Capital's largest Q3 2021 buy was Latham Group: 485,886 shares worth $7.97M.
  • Pier Capital added most to Poshmark, Inc. Class A Common Stock in Q3 2021, an estimated $8.26M increase.
  • Pier Capital's biggest Q3 2021 reduction was Sprout Social, cutting an estimated $7.13M.
  • Pier Capital fully exited TG Therapeutics in Q3 2021, selling an estimated $10.9M.
  • Pier Capital's ten largest holdings make up 15% of its $965M portfolio in Q3 2021.
  • Pier Capital opened 8 new positions and closed 5 in Q3 2021.
  • Pier Capital's portfolio value fell 3.2% quarter-over-quarter to $965M.

Based on Pier Capital's 13F filing for Q3 2021, filed 10 Nov 2021.